{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:04:58Z","timestamp":1786475098814,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04293-w","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:26:41Z","timestamp":1761118001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Whole-genome sequencing reveals resistance mechanisms and molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa bloodstream infections"],"prefix":"10.1186","volume":"25","author":[{"given":"Yongqin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"3","key":"4293_CR1","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1128\/aac.05991-11","volume":"56","author":"C Pena","year":"2012","unstructured":"Pena C, Suarez C, Gozalo M, Murillas J, Almirante B, Pomar V, et al. Prospective multicenter study of the impact of carbapenem resistance on mortality in <\u2009i\u2009>\u2009pseudomonas aeruginosa\u2009bloodstream infections. Antimicrob Agents Chemother. 2012;56(3):1265\u201372. https:\/\/doi.org\/10.1128\/aac.05991-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"4293_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/cid\/cit223","volume":"57","author":"C Pena","year":"2013","unstructured":"Pena C, Suarez C, Ocampo-Sosa A, Murillas J, Almirante B, Pomar V, et al. Effect of adequate Single-Drug vs combination antimicrobial therapy on mortality in <\u2009i\u2009>\u2009pseudomonas aeruginosa\u2009bloodstream infections: A post hoc analysis of a prospective cohort. Clin Infect Dis. 2013;57(2):208\u201316. https:\/\/doi.org\/10.1093\/cid\/cit223.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"4293_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrmicro2199","volume":"7","author":"AR Hauser","year":"2009","unstructured":"Hauser AR. The type III secretion system of <\u2009i\u2009>\u2009pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol. 2009;7(9):654\u201365. https:\/\/doi.org\/10.1038\/nrmicro2199.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"4293_CR4","doi-asserted-by":"publisher","first-page":"20719","DOI":"10.1038\/s41598-025-07820-x","volume":"15","author":"S Xiao","year":"2025","unstructured":"Xiao S, Zhu D, Liang X, Han L, Zhao S. Risk factors for multidrug resistant and carbapenem resistant Pseudomonas aeruginosa bloodstream infections among inpatients in central and East China. Sci Rep. 2025;15(1):20719. https:\/\/doi.org\/10.1038\/s41598-025-07820-x.","journal-title":"Sci Rep"},{"key":"4293_CR5","doi-asserted-by":"publisher","first-page":"1137811","DOI":"10.3389\/fmicb.2023.1137811","volume":"14","author":"Q Yuan","year":"2023","unstructured":"Yuan Q, Guo L, Li B, Zhang S, Feng H, Zhang Y, et al. Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in china: a 9-year trend and multicenter cohort study. Front Microbiol. 2023;14:1137811. https:\/\/doi.org\/10.3389\/fmicb.2023.1137811.","journal-title":"Front Microbiol"},{"key":"4293_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2147\/IDR.S396428","volume":"16","author":"X Wei","year":"2023","unstructured":"Wei X, Li L, Li M, Liang H, He Y, Li S. Risk factors and outcomes of patients with Carbapenem-Resistant Pseudomonas aeruginosa bloodstream infection. Infect Drug Resist. 2023;16:337\u201346. https:\/\/doi.org\/10.2147\/IDR.S396428.","journal-title":"Infect Drug Resist"},{"key":"4293_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jgar.2024.03.018","volume":"37","author":"F Yuan","year":"2024","unstructured":"Yuan F, Li M, Wang X, Fu Y. Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: A 10-year retrospective study. J Glob Antimicrob Resist. 2024;37:150\u20136. https:\/\/doi.org\/10.1016\/j.jgar.2024.03.018.","journal-title":"J Glob Antimicrob Resist"},{"issue":"8","key":"4293_CR8","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1128\/aac.38.8.1742","volume":"38","author":"XZ Li","year":"1994","unstructured":"Li XZ, Ma D, Livermore DM, Nikaido H, ROLE, OF EFFLUX PUMP(S) IN INTRINSIC RESISTANCE OF PSEUDOMONAS-AERUGINOSA - ACTIVE EFFLUX AS A CONTRIBUTING FACTOR TO BETA-LACTAM RESISTANCE. Antimicrob Agents Chemother. 1994;38(8):1742\u201352. https:\/\/doi.org\/10.1128\/aac.38.8.1742.","journal-title":"Antimicrob Agents Chemother"},{"key":"4293_CR9","doi-asserted-by":"publisher","unstructured":"Slama TG. Gram-negative antibiotic resistance: there is a price to pay. Crit Care. 2008;12. https:\/\/doi.org\/10.1186\/cc6820.","DOI":"10.1186\/cc6820"},{"issue":"4","key":"4293_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/cmr.00040-09","volume":"22","author":"PD Lister","year":"2009","unstructured":"Lister PD, Wolter DJ, Hanson ND. Antibacterial-Resistant\u2009<\u2009i\u2009>\u2009Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22(4):582\u2013. https:\/\/doi.org\/10.1128\/cmr.00040-09.","journal-title":"Clin Microbiol Rev"},{"key":"4293_CR11","doi-asserted-by":"publisher","unstructured":"Palzkill T. Metallo-\u03b2-lactamase structure and function. Ann N Y Acad Sci. 2013;1277. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06796.x.","DOI":"10.1111\/j.1749-6632.2012.06796.x"},{"issue":"9","key":"4293_CR12","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1128\/aac.01511-05","volume":"50","author":"X Jiang","year":"2006","unstructured":"Jiang X, Zhang Z, Li M, Zhou D, Ruan F, Lu Y. Detection of extended-spectrum \u03b2-lactamases in clinical isolates of <\u2009i\u2009>\u2009pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006;50(9):2990\u20135. https:\/\/doi.org\/10.1128\/aac.01511-05.","journal-title":"Antimicrob Agents Chemother"},{"key":"4293_CR13","doi-asserted-by":"publisher","unstructured":"Diaz MR, King JM, Yahr TL. Intrinsic and extrinsic regulation of type III secretion gene expression in <\u2009i\u2009>\u2009pseudomonas aeruginosa. Front Microbiol. 2011;2. https:\/\/doi.org\/10.3389\/fmicb.2011.00089.","DOI":"10.3389\/fmicb.2011.00089"},{"key":"4293_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5604\/01.3001.0010.3792","volume":"71","author":"F Al-Wrafy","year":"2017","unstructured":"Al-Wrafy F, Brzozowska E, Gorska S, Gamian A. Pathogenic factors of <\u2009i\u2009>\u2009pseudomonas aeruginosa - the role of biofilm in pathogenicity and as a target for phage therapy. Postepy Higieny I Medycyny Doswiadczalnej. 2017;71:78\u201391. https:\/\/doi.org\/10.5604\/01.3001.0010.3792.","journal-title":"Postepy Higieny I Medycyny Doswiadczalnej"},{"key":"4293_CR15","doi-asserted-by":"publisher","unstructured":"Hardy KS, Tuckey AN, Renema P, Patel M, Al-Mehdi A-B, Spadafora D, et al. ExoU induces lung endothelial cell damage and activates Pro-Inflammatory Caspase-1 during <\u2009i\u2009>\u2009pseudomonas aeruginosa\u2009infection. Toxins. 2022;14(2). https:\/\/doi.org\/10.3390\/toxins14020152.","DOI":"10.3390\/toxins14020152"},{"issue":"4","key":"4293_CR16","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1097\/CCM.0b013e3182377906","volume":"40","author":"AA El-Solh","year":"2012","unstructured":"El-Solh AA, Hattemer A, Hauser AR, Alhajhusain A, Vora H. Clinical outcomes of type iii\u2009<\u2009i\u2009>\u2009pseudomonas aeruginosa\u2009bacteremia. Crit Care Med. 2012;40(4):1157\u201363. https:\/\/doi.org\/10.1097\/CCM.0b013e3182377906.","journal-title":"Crit Care Med"},{"key":"4293_CR17","doi-asserted-by":"publisher","unstructured":"Howell HA, Logan LK, Hauser AR. Type III secretion of ExoU is critical during early\u2009<\u2009i\u2009>\u2009pseudomonas aeruginosa\u2009pneumonia. Mbio. 2013;4(2). https:\/\/doi.org\/10.1128\/mBio.00032-13.","DOI":"10.1128\/mBio.00032-13"},{"issue":"4","key":"4293_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/cid\/ciu866","volume":"60","author":"C Pena","year":"2015","unstructured":"Pena C, Cabot G, Gomez-Zorrilla S, Zamorano L, Ocampo-Sosa A, Murillas J, et al. Influence of virulence genotype and resistance profile in the mortality of <\u2009i\u2009>\u2009pseudomonas aeruginosa\u2009bloodstream infections. Clin Infect Dis. 2015;60(4):539\u201348. https:\/\/doi.org\/10.1093\/cid\/ciu866.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4293_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/s1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327. https:\/\/doi.org\/10.1016\/s1473-3099(17)30753-3.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"4293_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1080\/22221751.2022.2048972","volume":"11","author":"FC Tenover","year":"2022","unstructured":"Tenover FC, Nicolau DP, Gill CM. Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge. Emerg Microbes Infect. 2022;11(1):811\u20134. https:\/\/doi.org\/10.1080\/22221751.2022.2048972.","journal-title":"Emerg Microbes Infect"},{"key":"4293_CR21","doi-asserted-by":"publisher","unstructured":"Yuan Q, Guo L, Li B, Zhang S, Feng H, Zhang Y, et al. Risk factors and outcomes of inpatients with carbapenem-resistant\u2009<\u2009i\u2009>\u2009Pseudomonas aeruginosa\u2009bloodstream infections in china: a 9-year trend and multicenter cohort study. Front Microbiol. 2023;14. https:\/\/doi.org\/10.3389\/fmicb.2023.1137811.","DOI":"10.3389\/fmicb.2023.1137811"},{"issue":"12","key":"4293_CR22","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s10096-021-04308-0","volume":"40","author":"CM Gill","year":"2021","unstructured":"Gill CM, Aktap E, Alfouzan W, Bourassa L, Brink A, Burnham C-AD, et al. The ERACE-PA global surveillance program: ceftolozane\/tazobactam and ceftazidime\/avibactam in vitro activity against a global collection of Carbapenem-resistant\u2009<\u2009i\u2009>\u2009Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 2021;40(12):2533\u201341. https:\/\/doi.org\/10.1007\/s10096-021-04308-0.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"4293_CR23","doi-asserted-by":"publisher","first-page":"E159","DOI":"10.1016\/s2666-5247(22)00329-9","volume":"4","author":"J Reyes","year":"2023","unstructured":"Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, et al. Global epidemiology and clinical outcomes of carbapenem-resistant\u2009<\u2009i\u2009>\u2009Pseudomonas <\u2009i\u2009>\u2009aeruginosa\u2009and associated carbapenemases (POP): a prospective cohort study. Lancet Microbe. 2023;4(3):E159\u201370. https:\/\/doi.org\/10.1016\/s2666-5247(22)00329-9.","journal-title":"Lancet Microbe"},{"key":"4293_CR24","doi-asserted-by":"publisher","unstructured":"Yin S, Chen P, You B, Zhang Y, Jiang B, Huang G, et al. Molecular typing and carbapenem resistance mechanisms of <\u2009i\u2009>\u2009pseudomonas <\u2009i\u2009>\u2009aeruginosa\u2009isolated from a Chinese burn center from 2011 to 2016. Front Microbiol. 2018;9. https:\/\/doi.org\/10.3389\/fmicb.2018.01135.","DOI":"10.3389\/fmicb.2018.01135"},{"key":"4293_CR25","doi-asserted-by":"publisher","unstructured":"Beceiro A, Tomas M, Bou G. Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?? Clin Microbiol Rev. 2013;26(2):185\u2013230. https:\/\/doi.org\/10.1128\/cmr.00059-12.","DOI":"10.1128\/cmr.00059-12"},{"key":"4293_CR26","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1093\/infdis\/jiw402","volume":"215","author":"E Geisinger","year":"2017","unstructured":"Geisinger E, Isberg RR. Interplay between antibiotic resistance and virulence during disease promoted by Multidrug-Resistant bacteria. J Infect Dis. 2017;215:S9\u201317. https:\/\/doi.org\/10.1093\/infdis\/jiw402.","journal-title":"J Infect Dis"},{"key":"4293_CR27","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1093\/infdis\/jiw299","volume":"215","author":"C Juan","year":"2017","unstructured":"Juan C, Pena C, Oliver A. Host and pathogen biomarkers for severe\u2009<\u2009i\u2009>\u2009pseudomonas aeruginosa\u2009infections. J Infect Dis. 2017;215:S44\u201351. https:\/\/doi.org\/10.1093\/infdis\/jiw299.","journal-title":"J Infect Dis"},{"issue":"4","key":"4293_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/02713680500536746","volume":"31","author":"H Zhu","year":"2006","unstructured":"Zhu H, Conibear TCR, Bandara R, Aliwarga Y, Stapleton F, Willcox MDP. Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis. Curr Eye Res. 2006;31(4):297\u2013306. https:\/\/doi.org\/10.1080\/02713680500536746.","journal-title":"Curr Eye Res"},{"issue":"4","key":"4293_CR29","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3343\/alm.2014.34.4.286","volume":"34","author":"HH Cho","year":"2014","unstructured":"Cho HH, Kwon KC, Kim S, Koo SH. Correlation between virulence genotype and fluoroquinolone resistance in Carbapenem-Resistant\u2009<\u2009i\u2009>\u2009Pseudomonas aeruginosa. Annals Lab Med. 2014;34(4):286\u201392. https:\/\/doi.org\/10.3343\/alm.2014.34.4.286.","journal-title":"Annals Lab Med"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04293-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04293-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04293-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:26:41Z","timestamp":1761118001000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04293-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4293"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04293-w","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the Declaration of Helsinki. The relevant ethical approval has been obtained from the Ethical Committee of the First Affiliated Hospital of Nanchang University, with the approval number: IIT2025369. Given the retrospective nature of this cohort study using anonymous clinical data, the need for informed consent from participants was waived by the Ethical Committee of the First Affiliated Hospital of Nanchang University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"679"}}